CisplatinAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsQuality of LifeCombined Modality TherapyTreatment OutcomeDoxorubicinCyclophosphamideEtoposideDrug Administration ScheduleLung NeoplasmsDisease-Free SurvivalSurvival AnalysisDrug Resistance, NeoplasmNeoadjuvant TherapyVinblastinePaclitaxelNeoplasm StagingPlatinumCarboplatinSurvival RateDeoxycytidineOvarian NeoplasmsIfosfamideTaxoidsBreast NeoplasmsPrognosisMethotrexateCarcinoma, Non-Small-Cell LungVomitingNeoplasm Recurrence, LocalInduction ChemotherapyBleomycinTesticular NeoplasmsNeoplasmsNauseaCell Line, TumorAntimetabolites, AntineoplasticAdenocarcinomaCarcinoma, Squamous CellNeutropeniaHead and Neck NeoplasmsLeukopeniaInfusions, IntravenousAntineoplastic Agents, PhytogenicFollow-Up StudiesDose-Response Relationship, DrugCamptothecinTime FactorsMitomycinAntineoplastic Agents, AlkylatingSalvage TherapyNeoplasms, Germ Cell and EmbryonalNeoplasm MetastasisLifeStomach NeoplasmsTegafurApoptosisRadiotherapy, AdjuvantDrug Screening Assays, AntitumorAntiemeticsVindesineProspective StudiesCytarabineOrganoplatinum CompoundsAnthracyclinesGerminomaChemotherapy, Cancer, Regional PerfusionPlatinum CompoundsDrug SynergismCarmustineOxonic AcidRadiotherapyOsteosarcomaDNA AdductsInfusions, Intra-ArterialDacarbazineAntibiotics, AntineoplasticKaplan-Meier EstimateCarcinomaFluorouracilGranulocyte Colony-Stimulating FactorClinical Trials as TopicPeritoneal NeoplasmsTransplantation, AutologousRadiotherapy DosageThrombocytopeniaTumor Cells, CulturedBone NeoplasmsLymphoma, Non-HodgkinLiver NeoplasmsHodgkin DiseaseColorectal NeoplasmsBrain NeoplasmsLomustineCell SurvivalMelphalanDisease ProgressionPalliative Care